NUNaoko Ueda-Arakawa

Naoko Ueda-Arakawa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Naoko Ueda-Arakawa has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • High Prevalence of Anti-GD2 Immunotherapy-Associated Ocular Adverse Effects Following Allogeneic HCT for Neuroblastoma

    by Tomoi Furukawa, Ryo Akazawa, Katsutsugu Umeda, Shuro Nishio, Hirohito Kubota, Satoshi Saida, Itaru Kato, Naoko Ueda-Arakawa, Tatsuya Okamoto, Daisuke Fukao, et al.

    Background: GD2 is also expressed in normal ocular structures; however, much remains unknown about the risk factors for ocular adverse effects AEs following anti-GD2 immunotherapy remain unknown. Observations: We retrospectively analyzed risk factors for ocular AEs in 9 high-risk neuroblastoma patients. One of the 6 patients who underwent autologous hematopoietic cell transplantation (HCT) alone developed ocular AEs, whereas all 3 patients undergoing tandem autologous-allogeneic HCT did. Other variables, including age, history of anti-GD2 immunotherapy, and preimmunotherapy disease status, showed no significant association with ocular AEs. Conclusions: Allogeneic HCT before anti-GD2 immunotherapy may be a risk factor for ocular AEs.

  • ACUTE NEUROSENSORY RETINAL THINNING AND SHORT-TERM VISUAL OUTCOMES IN MASSIVE SUBMACULAR HEMORRHAGE: A LONGITUDINAL ANALYSIS FROM PRE-ONSET TO POST-DISPLACEMENT WITH SUBRETINAL TISSUE PLASMINOGEN ACTIVATOR

    by Lin Tsukui, Manabu Miyata, Masayuki Hata, Sotaro Ooto, Hiroshi Tamura, Ai Otsuka, Mai Shirakami, Naoko Ueda-Arakawa, Masahiro Miyake, Ayako Takahashi, et al.

    Purpose: To investigate longitudinal visual and structural changes from pre-onset to 1 month postoperatively in eyes with massive submacular hemorrhage (SMH) secondary to neovascular age-related macular degeneration (nAMD) treated with subretinal tissue plasminogen activator (tPA) injection and to identify prognostic factors for visual outcomes. Methods: This retrospective observational study reviewed the medical records of consecutive eyes with massive SMH secondary to nAMD treated with pars plana vitrectomy with subretinal tPA injection and pneumatic displacement. We assessed best-corrected visual acuity (BCVA) and foveal sensory retinal thickness (FSRT) at pre-onset, preoperative, and 1-month postoperative time points. Results: Among 74 consecutive eyes treated with subretinal tPA injection for massive SMH, we analyzed 20 eyes with available pre-onset data. FSRT decreased significantly from 193.5 ± 101.4 μm at pre-onset to 107.0 ± 59.0 μm at 1 month postoperatively ( P < 0.001). BCVA change negatively correlated with FSRT change (r = −0.56, P = 0.01). Univariable analysis showed that pre-onset BCVA significantly correlated with 1-month BCVA (r = 0.45, P = 0.049). At pre-onset, persistent fluid and pigment epithelial detachment were present in 65% and 15%, respectively. Conclusions: Massive SMH causes acute and profound neurosensory retinal thinning, and pre-onset neuronal integrity may be a key determinant of visual outcomes. Because surgery cannot reverse this immediate damage, preventing hemorrhage by maintaining a strictly fluid-free macula may be an important proactive strategy.

  • Open Access

    Impact of Reticular Pseudodrusen on Clinical and Ocular Characteristics and Progression Rate of Geographic Atrophy in Japanese Patients

    by Naoko Ueda-Arakawa, Yukiko Sato, Masahiro Miyake, Ayako Takahashi, Yuki Mori, Yasunori Miyara, Chikako Hara, Yoko Kitajima, Ruka Maruko, Moeko Kawai, et al.


  • Open Access

    Clinical Characteristics and Progression of Pachychoroid and Conventional Geographic Atrophy

    by Yukiko Sato, Naoko Ueda-Arakawa, Ayako Takahashi, Masahiro Miyake, Yuki Mori, Yasunori Miyara, Chikako Hara, Yoko Kitajima, Ruka Maruko, Moeko Kawai, et al.


  • Open Access

    Clinical Characteristics and Progression of Geographic Atrophy in a Japanese Population

    by Yukiko Sato, Naoko Ueda-Arakawa, Ayako Takahashi, Yasunori Miyara, Chikako Hara, Yoko Kitajima, Ruka Maruko, Moeko Kawai, Hajime Takahashi, Hideki Koizumi, et al.


    • 1 April 2011
      • Vol. 115  (4) , 391-7

    [A case of non-atherothrombotic cerebroretinal small vessel disease].

    by Naoko Arakawa, Satoshi Kashii, Kazuo Washida, Daita Kaneda, Hirokazu Masai, Kano Hiroi, Hogara Taguchi, Kazuya Fujiwara

    There is an increasing interest in the relation between retinal artery abnormalities and cerebral small-vessel diseases (SVD), because retinal vessels share common properties with cerebral small vessels. We report a case of juvenile cerebrovascular disease presenting retinal vessel abnormalities, which clinically resembled cerebral autosomal dominant arteriopathy with stroke and ischemic leukoencephalopathy (CADASIL) but in which Notch3 gene mutations were not detected. A 42-year old woman was hospitalized at the department of Neurology in our hospital, complaining of headache and dysarthria. MRI showed bilateral spotted white matter lesions in the paraventricular area and the temporal lobe, and an ovoid lesion in the right corona radiata. Despite steroid pulse therapy, she developed right incomplete hemiparesis and new lesions were detected in the anterior temporal pole and external capsule. Her genetic analysis showed no mutations in the Notch 3 gene. Ophthalmological examination revealed arterial sheathing in the peripapillary region. Fluorescein angiography showed narrowing of the retinal arterioles and distinguished a peripheral vascular network. In this case, ophthalmological examination revealed retinal vessel abnormalities in a relatively young woman with no risk factors such as hypertention or artheriosclerosis, presenting recurrent subcortical strokes. This actual case indicates the association between retinal vessel abnormalities and cerebral SVDs.